Director BIGAL MARCELO sold Pacira BioSciences ($PCRX) shares once on the open market in the last year for $116,267, with the most recent sale on August 7, 2025. This ranks 9,351st out of 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions. No open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2025 | Pacira BioSciences, Inc. | $PCRX | BIGAL MARCELO | Director | S | Common Stock | 4912 | $23.67 | 11,393.0000 | 46,245,000 | 30.13% | 0.01% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | BIGAL MARCELO | Director | A | Common Stock | 6163 | $0.00 | 16,305.0000 | 46,245,000 | 60.77% | 0.01% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | BIGAL MARCELO | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| Aug. 16, 2024 | Pacira BioSciences, Inc. | $PCRX | BIGAL MARCELO | Director | P | Common Stock | 1512 | $13.25 | 10,142.0000 | 51,979,000 | 17.52% | 0.00% |
| Aug. 12, 2024 | Pacira BioSciences, Inc. | $PCRX | BIGAL MARCELO | Director | P | Common Stock | 3400 | $12.01 | 8,630.0000 | 51,979,000 | 65.01% | 0.01% |
| Aug. 12, 2024 | Pacira BioSciences, Inc. | $PCRX | BIGAL MARCELO | Director | P | Common Stock | 3400 | $12.01 | 8,630.0000 | 51,979,000 | 65.01% | 0.01% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | BIGAL MARCELO | Director | A | Common Stock | 5230 | $0.00 | 5,230.0000 | 51,979,000 | 9999.99% | 0.01% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | BIGAL MARCELO | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| Oct. 6, 2023 | Pacira BioSciences, Inc. | $PCRX | BIGAL MARCELO | Director | A | Stock Option (Right to Buy) | 30967 | $0.00 | 30,967.0000 | 46,538,000 | 9999.99% | 0.07% |